Trust, Manchester M20 9BX, UK; 2Department of Surgical Gastroenterology, Manchester Royal Infirmary, Manchester M13 9WL, UK.Summary Low-level direct electric current has been shown to be capable of destroying tumour tissue. Using an early-passage subcutaneous murine mammary carcinoma, the relationships between the volume of tumour destruction, charge and polarity have been examined. The results revealed a direct correlation between charge passed and absolute volume regression when the intratumoral electrode was made either an anode or a cathode. Tumour destruction for a given charge was significantly greater following anodic than cathodic treatment. A direct correlation was also observed between the percentage volume of prompt treatment-induced regression and the in situ end point of tumour growth delay. During the course of these experiments, a highly reproducible toxic effect was discovered, which has not been previously reported for this modality. An anodic charge greater than 10.6 coulombs or a cathodic charge greater than 21.6 coulombs resulted in 100% mortality at 24-72 h, while lower charges had no influence on mortality. Quantitative assays of a number of blood parameters showed that mortality was associated with serum electrolyte imbalances and appeared to be the result of the metabolic load of tumour breakdown products. These effects are similar to the tumour lysis or surgical crush syndromes and should not constitute a significant problem in clinical practice, where the tumour mass to total body mass ratio will normally be much smaller.Direct current therapy (DCT) offers considerable promise as a low-cost, minimally invasive anti-tumour treatment. While the tissue-destructive effects of low, direct electrical currents have been known for many years, development of a clinically acceptable therapy has been slow, hindered, for example, by uncertainties regarding the quantitation of the dose-response relationship. Our previous qualitative study demonstrated that both anodic and cathodic treatments caused prompt and massive tumour necrosis (Dodd et al., 1993). The present work provides an absolute and relative quantitation of the extent of tumour regression/necrosis with charge and polarity. In common with previous workers, we noted that tumour lysis and volume decrease was extremely rapid after DCT. For other therapies, it has been observed clinically that an undesirable 'tumour lysis syndrome' may result in these circumstances (van der Hoven et al., 1992). Accordingly, we also examine here the potential systemic consequences of treating tumours by DCT.
Materials and methodsAll procedures to be described complied with the Animals (Scientific Procedures) Act 1986 (UK). Male B6DF21 (Paterson) mice, 6-8 weeks old, weight approximately 25 g, were inoculated subcutaneously with a suspension of cells from a low-passage, syngeneic murine mammary carcinoma, T50/80 (Moore, 1988). Tumours were treated by DCT 6-10 weeks after inoculation when they were approximately spherical and 6-1O mm in diameter. Tumour size was...